Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-18 | Immunovant, Inc. | Gloria Melanie
(Chief Operating Officer) |
A | Common Stock | A | 109956 | $0.00 - $0.00 | $0 |
| 2024-10-23 | Immunovant, Inc. | Levine Mark S.
(Chief Legal Officer) |
S | Common Stock | D | 4361 | $29.53 - $29.53 | $128,780 |
| 2024-10-16 | Immunovant, Inc. | Salzmann Peter
(Chief Executive Officer) |
S | Common Stock | D | 9095 | $28.79 - $28.79 | $261,845 |
| 2024-10-16 | Immunovant, Inc. | Levine Mark S.
(Chief Legal Officer) |
S | Common Stock | D | 2860 | $28.79 - $28.79 | $82,339 |
| 2024-10-16 | Immunovant, Inc. | Barnett Eva Renee
(Chief Financial Officer) |
S | Common Stock | D | 3271 | $28.79 - $28.79 | $94,172 |
| 2024-08-21 | Immunovant, Inc. | Levine Mark S.
(Chief Legal Officer) |
S | Common Stock | D | 3295 | $31.84 - $32.32 | $104,974 |
| 2024-08-21 | Immunovant, Inc. | Salzmann Peter
(Chief Executive Officer) |
S | Common Stock | D | 15068 | $31.84 - $32.32 | $480,051 |
| 2024-07-24 | Immunovant, Inc. | Levine Mark S.
(Chief Legal Officer) |
S | Common Stock | D | 4015 | $27.76 - $27.76 | $111,456 |
| 2024-07-17 | Immunovant, Inc. | Levine Mark S.
(Chief Legal Officer) |
S | Common Stock | D | 2505 | $29.64 - $30.55 | $74,381 |
| 2024-07-17 | Immunovant, Inc. | Macias William L.
(Chief Medical Officer) |
S | Common Stock | D | 3044 | $29.64 - $30.55 | $90,384 |
| 2024-07-17 | Immunovant, Inc. | Butchko Julia G.
(Chief Development Officer) |
S | Common Stock | D | 2867 | $29.64 - $30.55 | $85,130 |
| 2024-07-17 | Immunovant, Inc. | Salzmann Peter
(Chief Executive Officer) |
S | Common Stock | D | 8685 | $29.64 - $30.55 | $257,887 |
| 2024-07-09 | Immunovant, Inc. | Barnett Eva Renee
(Chief Financial Officer) |
S | Common Stock | D | 4747 | $28.06 - $28.06 | $133,200 |
| 2024-07-09 | Immunovant, Inc. | Butchko Julia G.
(Chief Development Officer) |
S | Common Stock | D | 1527 | $28.06 - $28.06 | $42,847 |
| 2024-07-09 | Immunovant, Inc. | Salzmann Peter
(Chief Executive Officer) |
S | Common Stock | D | 4619 | $28.06 - $28.06 | $129,609 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |